Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.
-
Bronchiolitis
-
Bronchiolitis
-
Bronchopulmonary Dysplasia
-
Bronchopulmonary Dysplasia
-
Child, Preschool
-
Child, Preschool
-
Double-Blind Method
-
Double-Blind Method
-
Follow-Up Studies
-
Follow-Up Studies
-
Heart Defects, Congenital
-
Heart Defects, Congenital
-
Hospitalization
-
Hospitalization
-
Humans
-
Humans
-
Immunoglobulins, Intravenous
-
Immunoglobulins, Intravenous
-
Infant
-
Infant
-
Infant, Newborn
-
Infant, Newborn
-
Infant, Premature
-
Infant, Premature
-
Pneumonia, Viral
-
Pneumonia, Viral
-
Respiratory Syncytial Virus Infections
-
Respiratory Syncytial Virus Infections
-
Respiratory Syncytial Virus, Human
-
Respiratory Syncytial Virus, Human
-
Risk Factors
-
Risk Factors
-
Treatment Outcome
-
Treatment Outcome